^
+ Follow AZITHROMYCIN Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1363612
                    [Title] => Ditch azithromycin in nongonococcal urethritis?
                    [Summary] => 

Recent evidence dictates the need to reassess the roles of doxycycline and azithromycin in treating Chlamydia trachomatis nongonococcal urethritis, according to Dr. Michel Janier.

[DatePublished] => 2014-08-31 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [1] => Array ( [ArticleID] => 915186 [Title] => Cases of resistant N. gonorrhoeae seen in San Diego [Summary] =>

Neisseria gonorrhoeae cases resistant to azithromycin detected in San Diego led the Centers for Disease Control and Prevention to issue a ”Dear Colleague” letter reminding clinicians to limit use of azithromycin monotherapy to treat uncomplicated rectal and genitourinary infections caused by N. gonorrhoeae.

[DatePublished] => 2013-03-03 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [2] => Array ( [ArticleID] => 901500 [Title] => Federal STD guidelines address shifting susceptibility [Summary] =>

Revised gonorrhea treatment regiment and expanded STD prevention recommendation are key features in updated Sexually Transmitted Disease Control and Prevention.

[DatePublished] => 2013-01-27 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [3] => Array ( [ArticleID] => 147970 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [4] => Array ( [ArticleID] => 147160 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [5] => Array ( [ArticleID] => 146351 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [6] => Array ( [ArticleID] => 145601 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [7] => Array ( [ArticleID] => 145284 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2001-12-29 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
AZITHROMYCIN
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1363612
                    [Title] => Ditch azithromycin in nongonococcal urethritis?
                    [Summary] => 

Recent evidence dictates the need to reassess the roles of doxycycline and azithromycin in treating Chlamydia trachomatis nongonococcal urethritis, according to Dr. Michel Janier.

[DatePublished] => 2014-08-31 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [1] => Array ( [ArticleID] => 915186 [Title] => Cases of resistant N. gonorrhoeae seen in San Diego [Summary] =>

Neisseria gonorrhoeae cases resistant to azithromycin detected in San Diego led the Centers for Disease Control and Prevention to issue a ”Dear Colleague” letter reminding clinicians to limit use of azithromycin monotherapy to treat uncomplicated rectal and genitourinary infections caused by N. gonorrhoeae.

[DatePublished] => 2013-03-03 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [2] => Array ( [ArticleID] => 901500 [Title] => Federal STD guidelines address shifting susceptibility [Summary] =>

Revised gonorrhea treatment regiment and expanded STD prevention recommendation are key features in updated Sexually Transmitted Disease Control and Prevention.

[DatePublished] => 2013-01-27 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) [3] => Array ( [ArticleID] => 147970 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [4] => Array ( [ArticleID] => 147160 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [5] => Array ( [ArticleID] => 146351 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [6] => Array ( [ArticleID] => 145601 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [7] => Array ( [ArticleID] => 145284 [Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections [Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.

Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2001-12-29 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with